Background {#Sec1}
==========

MEF2A is one of the members of the MEF2 family that belongs to the MADS-box superfamily and shares homology in a 58-amino acid domain that mediates DNA binding and dimerization \[[@CR1]\]. An MEF2A-encoded protein can act as a homodimer or heterodimer and is involved in several cellular processes, including neuronal differentiation, muscle development, cell growth control, and apoptosis \[[@CR2]\]. MEF2A has an essential DNA-binding site in the MyoDa gene control region and is a transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes \[[@CR3], [@CR4]\]. The critical roles of MEF2A in myocardial development have been confirmed in many studies. Naya et al. observed that mice lacking Mef2a die suddenly within the first week of life and exhibit pronounced right ventricle dilation, myofibrillar fragmentation, mitochondrial disorganization, and fetal cardiac gene program activation \[[@CR5]\]. Chen et al. found that MEF2A participates in the pathway mediating cardiomyocyte development by AKT2 \[[@CR6]\]. The association of genetic variations in the coding sequence of MEF2A with coronary artery disease (CAD) has also been broadly investigated. The deletion of seven amino acids disrupts the nuclear localization of MEF2A and reduces the MEF2A-mediated activation of transcription, and this deletion is co-segregated with premature CAD in a family lineage \[[@CR7]\]. Another study has reported that a novel 6 bp deletion in exon 11 of MEF2A is closely associated with premature CAD \[[@CR8]\]. Nonsynonymous mutation or variation in the number of CAG or CCG repeats is correlated with susceptibility to CAD in some populations \[[@CR9], [@CR10]\]. However, the roles of MEF2A variants in CAD are controversial because not all studies can show the association between these variants and CAD \[[@CR11]--[@CR15]\]. The inflammation and dysfunction of vascular endothelial cells or smooth muscle cells are implicated in the pathogenesis of CAD. MEF2A promotes vascular smooth muscle cell (VSMC) senescence and regulates H~2~O~2~-induced VSMC senescence by interacting with miR-143, and MEF2A inhibition induces the phenotypic switching of VSMCs, leading to increased cell proliferation and migration \[[@CR16], [@CR17]\]. Kim et al. demonstrated that the activity of MEF2 (MEF2A and MEF2C) is remarkably impaired in pulmonary arterial endothelial cells derived from the subjects with pulmonary arterial hypertension (PAH), and the restoration of the impaired function of endothelial MEF2 rescues PAH \[[@CR18]\]. Silencing of MEF2A in apoE^−/−^ mice by using lentiviral shRNA considerably reduces plaque collagen content and fibrous cap thickness and increases plaque area; conversely, silencing of MEF2A has no obvious effect on plaque lipid content \[[@CR19]\]. These studies have suggested that MEF2A plays important roles in cardiomyocytes, VSMCs, and pulmonary arterial endothelial cells, but its functions in coronary artery endothelial cells are unclear. In this study, we found that the inhibition of MEF2A by siRNA promoted HCAEC senescence. To explore the transcriptional change in the downstream molecular network in response to MEF2A knockdown, we conducted mRNA microarray analysis and revealed that many specific pathways might be regulated by MEF2A in HCAECs. We also described a downstream molecular network controlled by MEF2A.

Results {#Sec2}
=======

Inhibition of MEF2A in HCAECs promoted cellular senescence and suppressed proliferation {#Sec3}
---------------------------------------------------------------------------------------

In this study, we attempted to understand the effect of inhibiting the MEF2A expression on HCAECs. Four pairs of MEF2A-specific siRNA were designed to suppress the MEF2A expression, and MEF2A-1527 showed the highest inhibitory activity on the expression of MEF2A (Fig. [1](#Fig1){ref-type="fig"}a). MEF2A-1527 had a significant inhibitory effect on MEF2A when it was transfected at different concentrations in HCAEC (Fig. [1](#Fig1){ref-type="fig"}b), and a final concentration of 40 nM MEF2A-1527 remarkably inhibited MEF2A at both mRNA (Fig. [1](#Fig1){ref-type="fig"}c) and protein (Fig. [1](#Fig1){ref-type="fig"}d) levels in HCAEC. The results of senescence-associated β-galactosidase (SA-β-Gal) staining and EdU staining showed that MEF2A knockdown accelerates HCAEC senescence (Fig. [2](#Fig2){ref-type="fig"}a) and inhibites cell proliferation (Fig. [2](#Fig2){ref-type="fig"}b).Fig. 1MEF2A was inhibited by siRNA on mRNA and protein level. **a** The inhibition efficiency of four pairs of MEF2A specific siRNA. **b** The inhibition efficiency of different concentration of MEF2A-1527. **c**, **d** Variation of the expression of MEF2A at mRNA and protein levels in HCAEC transfected with MEF2A-1527 at a final concentration of 40 nM Fig. 2Alteration in phenotype of HCAEC in response to MEF2A knockdown. NC: negative control; MEF2A-SI: MEF2A silencing. **a** Senescent cells were detected using SA-β-Gal staining at 96 h after transfection and senescent cells were stained blue. **b** The proliferative capability of cells were tested by using EdU staining at 96 h after transfection and the cells stained purple have proliferative activity

Identification of DEGs in response to MEF2A knockdown in HCAECs {#Sec4}
---------------------------------------------------------------

The MEF2A-specific siRNA group and the negative control group were subjected to genome-wide expression microarray analyses to determine the underlying regulatory network in response to the inhibition of MEF2A. The raw microarray data obtained in this experiment were deposited in Gene Expression Omnibus (GEO) \[[@CR20]\] with an accession number of GSE114114. A total of 1363 genes had more than twofold changes in the expression between the MEF2A knockdown group and the NC group, and the difference in the gene expression patterns could be seen in the heat map (Fig. [3](#Fig3){ref-type="fig"}a). The DEGs, namely, MEF2A, SERPINP, IL1B, ENPP1, ZAK, PIK3CG, FOS, MMP1, HLA-DQB1, GUCY1A3, MYL9, GJA5, and CSF2, were selected for real-time q-PCR validation. Up-regulation of MMP1 and MYL9 and downregulation of the other genes except GJA5 in the MEF2A-siRNA group were observed in qPCR and microarray. The microarray result showed that GJA5 was significantly down-regulated, but the qPCR result revealed that GJA5 was up-regulated in the MEF2A-siRNA group (Fig. [3](#Fig3){ref-type="fig"}b).Fig. 3DEGs between MEF2A silencing group and NC-group. **a** The heatmap of the DEGs. Three groups of HCAEC transfected with MEF2A-1527 were respectively indicated with 1527-1, 1527-2 and 1527-3. The mixed sample with three groups of HCAEC transfected with negative control siRNA was defined as NC. **b**, **c** The selected DEGs were validated with real-time quantitative PCR. The relative expression of each gene was calculated according to 2^−((Cte1−Cte0)\ −(Ctn1−Ctn0))^, here, C~te1~ and C~te0~ respectively indicate the C~t~ value of the target gene and the internal reference gene (beta-actin) in MEF2A siRNA-groups; C~tn1~ and C~tn0~ respectively indicate the C~t~ value of the target gene and beta-actin in the NC groups. The relative expression of all selected genes was normalized to "1" in the NC groups. **c** These genes have at least one potential MEF2A binding site in its proximal promoter. \**p* \< 0.05, \*\**p *\< 0.01, \*\*\**p* \< 0.001 are significant

Of the down-regulated DEGs, 61 were predicted with at least one MEF2A binding site in the proximal promoter (500 bp region upstream from the transcription start site) (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Database for Annotation, Visualization, and Integrated Discovery (DAVID) analysis of the 61 genes indicated that many genes were significantly enriched in the terms "reproduction" and "cardiovascular" in the GAD_DISEASE_CLASS category. The terms "secreted," "disulfide bond," "signal peptide," and "zinc finger region:B box-type" were the most significantly enriched (Table [1](#Tab1){ref-type="table"}). A few of these DEGs were selected for qPCR validation, and the expression of TRIM7, SGK196, BCL2A1, NR5A2, and ANK3 significantly differed between the two groups (Fig. [3](#Fig3){ref-type="fig"}c). These findings suggested for the first time that the expression of these genes may be directly mediated by MEF2A.Table 1GO annotation for the down-regulated DEGs with potential MEF2A binding sites in the proximal promoterCategoryTermCount (%)*p*-valueFold enrichmentGAD_DISEASE_CLASSReproduction8 (13.33)0.032942.51GAD_DISEASE_CLASSCardiovascular21 (35)0.033161.48UP_KEYWORDSSecreted18 (30)0.000023.14UP_KEYWORDSDisulfide bond21 (35)0.000972.10UP_KEYWORDSSignal23 (38.33)0.001811.90UP_KEYWORDSGlycoprotein22 (36.67)0.012481.66UP_KEYWORDSCell junction7 (11.67)0.012573.56UP_KEYWORDSCell membrane16 (26.67)0.031431.73UP_KEYWORDSCitrullination3 (5)0.0316110.61UP_KEYWORDSActin-binding4 (6.67)0.043975.01UP_KEYWORDSThick filament2 (3.33)0.0476540.35UP_SEQ_FEATURESignal peptide23 (38.33)0.000122.30UP_SEQ_FEATUREDisulfide bond19 (31.67)0.001322.18UP_SEQ_FEATUREZinc finger region:B box-type3 (5)0.0171014.75UP_SEQ_FEATUREGlycosylation site:N-linked (GlcNAc.)20 (33.33)0.030951.58UP_SEQ_FEATUREDomain:B30.2/SPRY3 (5)0.0331210.34

DEGs in response to MEF2A knockdown were mostly enriched in the DAVID GO terms related to growth, signal transduction and inflammation {#Sec5}
--------------------------------------------------------------------------------------------------------------------------------------

Excluding the DEGs that lacked the ENTREZ GENE ID information, we found that 384 and 578 of 962 DEGs were up-regulated and down-regulated, respectively (Additional file [2](#MOESM2){ref-type="media"}: Table S2). The annotation clusters containing GO terms, including glycoprotein, glycosylation site:N-linked (GlcNAc), signal peptide, disulfide bond, secreted, and signal, were significantly enriched in the DEGs (Additional file [3](#MOESM3){ref-type="media"}: Table S3). Functional GO term enrichment analysis revealed that preferential changes in the expression of the genes in response to MEF2A knockdown were involved in diverse biological processes, including "female pregnancy," "cell--cell signaling," and "metabolic process." The DEGs were likely implicated in many molecular functions, including "phosphatidylinositol-4,5-bisphosphate 3-kinase activity," "cytokine activity," "serine-type endopeptidase inhibitor activity," and "growth factor activity" (Table [2](#Tab2){ref-type="table"}). The most significantly enriched GO terms in cellular component included extracellular space, extracellular region, and plasma membrane (Table [2](#Tab2){ref-type="table"}). Pathway enrichment analysis showed that most of the DEGs down-regulated by the MEF2A knockdown were enriched in immune-related pathways (Table [3](#Tab3){ref-type="table"}). These GO terms are closely associated with growth, development, cell survival, and inflammation, suggesting the extensive involvement of MEF2A in mediating cell functions.Table 2The top 10 enriched biological process, cell component and molecular function GO terms for DEGs, which were sorted respectively by *p*-value in ascendingCategoryTermCount*p*-valueFold enrichmentGOTERM_BP_DIRECTGO:0007565 \~ female pregnancy132.86E−043.534242GOTERM_BP_DIRECTGO:0007267 \~ cell--cell signaling243.61E−042.286233GOTERM_BP_DIRECTGO:0008152 \~ metabolic process185.93E−042.592425GOTERM_BP_DIRECTGO:0007165 \~ signal transduction690.0021681.438003GOTERM_BP_DIRECTGO:0001525 \~ angiogenesis200.0023022.170042GOTERM_BP_DIRECTGO:0008277 \~ regulation of G-protein coupled receptor protein signaling pathway70.004934.342866GOTERM_BP_DIRECTGO:0030168 \~ platelet activation120.0079562.524796GOTERM_BP_DIRECTGO:0006687 \~ glycosphingolipid metabolic process70.0099973.763817GOTERM_BP_DIRECTGO:0071526 \~ semaphorin--plexin signaling pathway60.0107374.399266GOTERM_BP_DIRECTGO:0016266 \~ *O*-glycan processing80.0114513.226129GOTERM_CC_DIRECTGO:0005615 \~ extracellular space1091.54E−111.95324GOTERM_CC_DIRECTGO:0005576 \~ extracellular region1232.57E−111.844064GOTERM_CC_DIRECTGO:0005886 \~ plasma membrane2141.33E−041.253453GOTERM_CC_DIRECTGO:0005578 \~ proteinaceous extracellular matrix253.33E−042.251656GOTERM_CC_DIRECTGO:0016021 \~ integral component of membrane2510.0017391.17346GOTERM_CC_DIRECTGO:0005581 \~ collagen trimer110.0046862.886035GOTERM_CC_DIRECTGO:0009986 \~ cell surface360.006311.603245GOTERM_CC_DIRECTGO:0005887 \~ integral component of plasma membrane760.0156031.296444GOTERM_CC_DIRECTGO:0002177 \~ manchette30.01572814.48265GOTERM_CC_DIRECTGO:0005884 \~ actin filament80.0175552.9708GOTERM_MF_DIRECTGO:0046934 \~ phosphatidylinositol-4,5-bisphosphate 3-kinase activity108.46E−043.963234GOTERM_MF_DIRECTGO:0005125 \~ cytokine activity188.47E−042.513051GOTERM_MF_DIRECTGO:0004867 \~ serine-type endopeptidase inhibitor activity120.0019153.039842GOTERM_MF_DIRECTGO:0008083 \~ growth factor activity160.0025312.426869GOTERM_MF_DIRECTGO:0008201 \~ heparin binding150.0057352.30363GOTERM_MF_DIRECTGO:0008401 \~ retinoic acid 4-hydroxylase activity30.00936818.42904GOTERM_MF_DIRECTGO:0005102 \~ receptor binding250.0099771.74023GOTERM_MF_DIRECTGO:0005509 \~ calcium ion binding420.0173681.439367GOTERM_MF_DIRECTGO:0032395 \~ MHC class II receptor activity40.0210976.552547GOTERM_MF_DIRECTGO:0001665 \~ alpha-*N*-acetylgalactosaminide alpha-2,6-sialyltransferase activity30.02218212.28603 Table 3The top 10 significant KEGG pathway enriched in the down-regulated DEGsCategoryTermCount*p*-valueFold enrichmentKEGG_PATHWAYhsa05146:amoebiasis119.00E−043.585377KEGG_PATHWAYhsa05164:influenza A140.0014682.779885KEGG_PATHWAYhsa04650:natural killer cell mediated cytotoxicity110.0026163.115164KEGG_PATHWAYhsa05323:rheumatoid arthritis90.0036773.533523KEGG_PATHWAYhsa05150:*Staphylococcus aureus* infection70.0043234.478704KEGG_PATHWAYhsa04612:antigen processing and presentation80.0060253.636842KEGG_PATHWAYhsa04610:complement and coagulation cascades70.0140783.505072KEGG_PATHWAYhsa05143:African trypanosomiasis50.0142075.234848KEGG_PATHWAYhsa05332:graft-versus-host disease50.0142075.234848KEGG_PATHWAYhsa04740:olfactory transduction200.0206971.73183

PIK3CG and several chemotactic factors were included in the hot nodes in protein--protein interaction (PPI) networks {#Sec6}
--------------------------------------------------------------------------------------------------------------------

The PPI network of the down-regulated DEGs contained 502 nodes and 281 edges, and the *p*-value of PPI enrichment was \< 1.0 × 10^−16^. Most of the downregulated DEGs formed a complicated interaction network (Fig. [4](#Fig4){ref-type="fig"}a). GNG13, GNG2, GABBR2, CXCR7, CXCL3, IL8, CNR1, IL1B, PRKCB, PMCH, P2RY14, and PIK3CG were presented at the hot nodes and may play important roles in the biological process (Fig. [4](#Fig4){ref-type="fig"}a). The majority of the genes in the network were significantly enriched (FDR \< 0.01) in the categories of extracellular space and extracellular region in the GO term of cellular component, and many of these genes were involved in signal transduction (Table [4](#Tab4){ref-type="table"}). The KEGG pathways "amoebiasis, *Staphylococcus aureus* infections, influenza A, rheumatoid arthritis, and olfactory transduction" were significantly enriched (FDR \< 0.05) for the DEGs in the PPI network (Table [4](#Tab4){ref-type="table"}). However, most of the up-regulated genes are independent of each other and only a small number of them can form an interaction network (Fig. [4](#Fig4){ref-type="fig"}b).Fig. 4The functional association protein networks were constructed with STRING for the DEGs. Settings for the interaction search as follows: minimum required interaction score is ≥ 0.7 (high confidence); active interaction sources are Textmining, Experiments, Databases, Co-expression, Neighborhood, Gene Fusion and Co-occurrence; the max number of interactors to show is query proteins only for the first shell and none for the second shell; hide the disconnected nodes in the network. The pies indicated nodes and the full line indicated the edges of the PPI network. **a** Network for down-regulated genes. **b** Network for UP-regulated genes Table 4GO annotation for the down-regulated DEGs in the PPI networkPathway IDPathway descriptionCount in gene setFalse discovery rate (FDR)Biological process (GO) GO:0050793Regulation of developmental process840.000902 GO:0048387Negative regulation of retinoic acid receptor signaling pathway80.00358 GO:0051239Regulation of multicellular organismal process880.00358 GO:0045595Regulation of cell differentiation600.00957 GO:0050995Negative regulation of lipid catabolic process60.00957Cellular component (GO) GO:0005615Extracellular space668.23e−07 GO:0005576Extracellular region1450.000952 GO:0071944Cell periphery1430.0129 GO:0005886Plasma membrane1390.0259KEGG pathways 05146Amoebiasis100.0173 05150*Staphylococcus aureus* infection70.0173 05164Influenza A140.0173 05323Rheumatoid arthritis90.0173 04740Olfactory transduction210.0413

In order to discover the genes possibly involved in related diseases, the DEGs were annotated to the category "GAD_DISEASE_CLASS" and the terms "metabolic, chemdependency, cardiovascular, hematological, psych, neurological, renal, vision, pharmacogenomic, reproduction, normal variation, immune, aging, and developmental" were preferentially enriched (Fig. [5](#Fig5){ref-type="fig"}a). Among the DEGs in the GO term "aging," 23 were up-regulated and 33 were down-regulated. The PPI network of the DEGs in the GO term "aging" showed that 22 DEGs, including PIK3CG, TXK, HDAC9, PPARG, IL1B, IL8, and PCK1, were in a correlative interaction network (Fig. [5](#Fig5){ref-type="fig"}b). A PPI network analysis performed for 244 DEGs in the GO term "cardiovascular" showed that these genes had more interactions among themselves than the expected observation (PPI enrichment *p* \< 1 × 10^−16^), suggesting that the genes were biologically connected as a group (Fig. [5](#Fig5){ref-type="fig"}c). PIK3CG, IL8, IL1B, and CSF were included in the hot nodes with multiple interactions, implying their major role in the GO terms "aging" and "cardiovascular." Further validation experiments showed that the mRNA and protein levels of PIK3CG were significantly down-regulated when MEF2A was inhibited (Fig. [6](#Fig6){ref-type="fig"}a), while the mRNA and protein levels of PIK3CG were significantly up-regulated when overexpressing MEF2A (Fig. [6](#Fig6){ref-type="fig"}b).Fig. 5Enrichment of the GO terms in GAD_DISEASE_CLASS for the DEGs and PPI network for certain GO term 'aging' and 'cardiovascular' related DEGs. In the PPI network, each node represents all the proteins produced by a single, protein-coding gene locus. Edges represent protein--protein associations, and associations are meant to be specific and meaningful. **a** The Go terms significantly enriched for the DEGs. **b** Interaction network for the DEGs enriched in the GO term 'aging'. A "d" indicates a gene with down-regulatory signal on the microarray. A "u" indicates a gene with up-regulatory signal on the microarray. **c** Interaction network for the DEGs enriched in the GO term 'cardiovascular' Fig. 6The expression of PIK3CG varies with the level of MEF2A. **a**, **b** Changes in the expression of PIK3CG at the mRNA and protein levels when MEF2A is inhibited; NC: transfected with negative control siRNA; MEF2A-SI: transfected with MEF2A specific siRNA (MEF2A-1527). **c**, **d** Changes in the expression of PIK3CG at mRNA and protein levels when MEF2A was over-expressed

Discussion {#Sec7}
==========

In the present study, inhibition of MEF2A by siRNA promoted HCAEC senescence, suggesting that it has an anti-aging functional role. This protective role appears to be different from its role in VSMC, which exhibits a detrimental aging-promoting role \[[@CR16], [@CR17]\]. However, an in vivo research has shown that MEF2A may have an anti-atherosclerotic function in ApoE^−/−^ mice \[[@CR19]\], and functional deletion in MEF2A gene is co-segregated with premature CAD in several family lineages \[[@CR7], [@CR8]\], suggesting the protective role of MEF2A in vessels. The above findings imply that a decrease in MEF2A expression in vascular endothelial cells may result in vessel dysfunction. Therefore, it is important to understand the profile and the interaction network of the DEGs affected by knockdown of MEF2A in HCAEC.

In our study, the DEGs in response to MEF2A knockdown were significantly enriched in the GO terms associated with growth, proliferation, development, survival, and inflammation. The down-regulated genes in MEF2A-knocked down HCAECs were involved in a complicated regulatory network. Among the hot nodes, PIK3CG, PRKCB, and IL8 have been extensively investigated. PIK3CG plays important roles in immunity, hypertension, longevity, and circulation \[[@CR21], [@CR22]\]. p110γ, the encoding protein of PIK3CG, is principally involved in the control of leukocyte chemotaxis and inflammatory reactions in the immune system, affects multiple aspects of adrenergic receptor signaling and cardiac function in cardiomyocytes \[[@CR21]\], and participates in angiotensin II induced calcium influx and governing the vascular contractile response \[[@CR22]\]. Thus, p110γ has been considered as a promising target for drug design in the treatment of heart failure and hypertension, whereas the function of p110γ in vascular endothelial cells is unclear. In our study, the GO term analysis based on the GAD_disease indicated that PIK3CG participated in the aging pathway and interacted with many inflammatory factors in the PPI network. In practice, mass evidences have indicated that PI3K pathway is involved in cellular senescence and proliferation \[[@CR23]--[@CR26]\]. In the present study, multiple experiments showed that the expression of PIK3CG varied with the expression level of MEF2A, suggesting that the expression of PIK3CG is regulated by MEF2A. The expression of PIK3CG was significantly down-regulated in MEF2A-knocked down HCAECs, suggesting that PIK3CG may be involved in the molecular mechanism of MEF2A silencing induced senescence. In addition, many inflammatory factors were overtly down-regulated simultaneously with PIK3CG, indicating that the down-regulation of inflammatory factors in response to MEF2A silencing might be mediated by PIK3CG.

PRKCB might promote the removal of LDLs from the blood by increasing the expression of LDLR and SR-A and reducing foam cell formation, which might mitigate atherogenesis. However, the characteristics of PRKCB that plays a pro-inflammatory role in endothelial cells and promotes VSMC proliferation and migration are associated with pro-atherosclerosis as observed in PRKCB knockout mice \[[@CR27]\].

IL8 is another extensively studied gene that serves as a risk factor of cardiovascular disease \[[@CR28]\]. The PPI network shows a large number of interactions between IL8 and other genes, suggesting that MEf2A-mediated inflammatory pathway might greatly depend on the participation of IL-8. Suzuki et al. \[[@CR29]\] revealed that MEF2A may mediate vascular inflammation by stimulating MCP-1 expression in VSMCs and macrophage infiltration. MEF2A and MEF2D may function as activators or repressors of gene transcription in human macrophages \[[@CR30]\]. In our study, many genes involved in macrophage infiltration were downregulated in MEF2A-knocked down HCAECs, suggesting the role of MEF2A in regulating inflammation. Furthermore, 8 of the top 10 KEGG pathways enriched by the down-regulated DEGs were involved in immune-related diseases, indicating that MEF2A participated in mediating the immune system.

Guanine nucleotide binding protein subunit gamma 2 and 13 (GNG2 and GNG13) play key roles in signal transduction pathways. In our study, they were significantly down-regulated in MEF2A-knocked down HCAECs. GNG13 is colocalized with alpha-gustducin in taste receptor cells, and antibodies against Ggamma13 block the denatonium-induced increase in inositol trisphosphate (IP3) in taste tissue \[[@CR31]\]. In our study, most olfactory receptors were distinctively down-regulated in MEF2A-knocked down HCAECs, and almost all of them interacted with GNG13 in the PPI network. These findings suggested that the expression of olfactory receptors might be regulated by MEF2A through GNG13 and PI3K.

DAVID GO functional annotation enrichment based on GAD revealed that the cardiovascular system was one of the most prominently enriched terms of the DEGs in response to MEF2A knockdown. More than 200 DEGs were related to the cardiovascular system and exhibited complicated interactions with one another. Many hot nodes in the PPI network are inflammatory factors, including IL8, IL1B, CXCL3, CXCL12, and HLA genes, which are associated with cardiovascular diseases \[[@CR28], [@CR32]--[@CR34]\]. MEF2A functional deletion carriers were subjected to premature CAD \[[@CR7], [@CR8]\], strongly supporting the important roles of MEF2A in providing protection against cardiovascular disease. Our findings show that numerous genes in inflammatory pathways were down-regulated as MEF2A was silenced, indicating that MEF2A may be an important regulator to mediate the expression of inflammatory factors, and that this role of MEF2A appears to be inconsistent with its protective effect against CAD. Alternative splicing of the pre-mRNA of MEF2A resulted in different isoforms which have distinct activity and are differentially distributed in various tissues \[[@CR35]\]. Aberrant alternative splicing isoforms were observed to be associated with myotonic dystrophy and neuromuscular disorders \[[@CR36]\]. More than 20 MEF2A isoforms have been submitted to NCBI database so far. Yet the functional diversity of the isoforms is unclear. Silencing of MEF2A by siRNA may alter the proportion of different splicing isoforms compared to in the normal physiological status of the cells. Therefore, when we attempt to explore the underlying molecular mechanism that MEF2A participate in a certain biological or pathological process, which MEF2A alternative splicing isoforms exert major effect on the process should be taken into account. We found that the functional role of MEF2A in vascular endothelial cells is inconsistent with its roles in VSMC reported by other studies, possibly due to differential splicing of MEF2A in the two kinds of cells.

Among the down-regulated DEGs, 61 genes were found with at least one potential MEF2A binding site in the proximal promoter. If extended the search region in the promoters of the DEGs, there would be more genes found with MEF2A binding sites. Therefore, many DEGs may be directly regulated by MEF2A via binding to their cis-elements in the promoters. TRIM7, SGK196, BCL2A1, NR5A2, ANK3 and PYHIM9 have MEF2A binding site in their proximal promoter, which were down-regulated in MEF2A-knocked down HCAEC via verifying by qPCR. These genes are respectively involved in metabolism, development, differentiation, apoptosis and survival \[[@CR37], [@CR38]\].

Conclusion {#Sec8}
==========

MEF2A knockdown in HCAECs promotes cell senescence and remarkably alters mRNA profile, primarily related to signal transduction, proliferation, development, inflammation, and other processes, and may lead to cell dysfunction by promoting cellular senescence and inflammation or by inhibiting cell proliferation. PIK3CG has been shown to be associated with longevity, and its expression varies with the expression level of MEF2A in HCAEC, suggesting that PIK3CG may play an important role in cell senescence induced by MEF2A silencing.

Materials and methods {#Sec9}
=====================

Cell culture {#Sec10}
------------

The primary HCAECs were purchased from Cell Applications and cultured in EGM-2 medium (Lonza, USA) supplemented with growth factors. The cells were further grown at 37 °C in a humidified atmosphere with 5% (v/v) CO~2~ and passaged at 1:3 when they reached approximately 85--95% confluency.

Construction of MEF2A overexpression plasmid {#Sec11}
--------------------------------------------

The complete MEF2A coding region fragment was amplified using high fidelity PCR polymerase and cDNA template derived from HCAEC, and the amplified fragment was ligated into the mammalian expression vector pc3-gab at the sites *Eco*RI and *Bgl*II. Then, transformation and plasmid extraction were performed, and the inserted encoding sequence was verified by Sanger sequencing to be same to the MEF2A alternative splice variant XM_005254915.2_V\_X15.

Transfection {#Sec12}
------------

siRNA was diluted to a 20 μM solution with RNAse-free and sterile deionized water and stored below − 20 °C. HCAECs were seeded in a plate at a density of 7500 cells/cm^2^ 18--24 h before transfection and cultured at 37 °C in a humidified atmosphere with 5% (v/v) CO~2~. Lipofectamine^®^ RNAiMAX and Lipofectamine^®^ 3000 reagent were respectively used to guide siRNA and plasmids into the cells, and the procedure was performed in accordance with the manufacturer's instructions. The next treatments were performed at 72 h post-transfection.

Detection of cell senescence and proliferation {#Sec13}
----------------------------------------------

The cells were subjected to SA-β-Gal staining by using a β-galactosidase staining kit (Cell Signaling Technology, USA) in accordance with the manufacturer's instructions. The stained cells were examined with a high-resolution microscope at 400× magnification, and blue stain corresponded to senescent cells. Cell proliferation was detected with an EdU staining kit (Ribobio, China) in accordance with the manufacturer's instructions. The stained cells were imaged with a fluorescence inversion microscope system at 400× magnification, and purple stain indicated proliferating cells. The senescence rate and the proliferation rate were respectively determined by calculating the proportion of the senescent cells and the proliferating cells in the total number of cells in 15 visions per well. The results were expressed as the mean of triplicates ± standard error of the mean (SEM).

RNA isolation {#Sec14}
-------------

Total RNA of cells was isolated with Trizol reagent (Invitrogen, Carlsbad, USA) in accordance with the manufacturer's protocol. RNA concentration was determined by measuring the absorbance at 260 nm with a NanoVue spectrophotometer (GE Healthcare, UK). RNA integrity was assessed through electrophoresis on agarose gel.

Microarray analysis {#Sec15}
-------------------

Three independent groups of HCAECs transfected with MEF2A-specific siRNA (MEF2A-Homo-1527) were separately analyzed with an Agilent human mRNA array (AHMA), and three independent groups of HCAECs transfected with negative control siRNA were collected together into a tube. RNA was extracted for AHMA analysis. Three MEF2A-specific siRNA groups were indicated as 1527-1, 1527-2, and 1527-3, and the mixed control group was designated as NC. The AHMA was designed with eight identical arrays/slide (8 × 60 K format), and each array contained probes examining about 27,958 Entrez gene RNAs. The whole microarray analyses, including sample preparation, labeling, hybridization, scanning, and treatment of original data, were processed by CapitalBio Corporation (Beijing, China). DEGs were analyzed by using the DAVID v6.8, and a protein--protein interaction (PPI) network was searched using the STRING tool \[[@CR39]\]. The DEGs containing a potential MEF2A binding site in their promoter were predicted with LASAGNA-Search 2.0 \[[@CR40]\].

Real-time fluorescence quantitative PCR (q-PCR) {#Sec16}
-----------------------------------------------

Total RNA was reverse transcribed by using a ReverTra Ace qPCR RT kit (Toyobo, Japan), and q-PCR was performed with SYBR^®^ Green mix (Takara, China) in accordance with the manufacturer's instructions. Alteration in the gene expression relative to the control group was analyzed with a comparative CT method by using beta-actin for endogenous control and NC cell for calibration. The primers used in this study are shown in Table [5](#Tab5){ref-type="table"}.Table 5The primer sequences for real time quantitative PCRSerial no.GenesForward primer (5′ to 3′)Reverse primer (5′ to 3′)Tm (°C)1MEF2AAGCAGCCCTCAGCTCTCTTGGGTGAAATCGGTTCGGACTTG602PIK3CGTCCTCTTTGTGATGGGAACTTTGTGTGATGACGAAGGGCT603SERPIND1TGATTCTCAACTGCATCTACTTCCCTCTCTCTCATTCAGCCG604IL1BACAGTGGCAATGAGGATGTGTAGTGGTGGTCGGAGA605ENPP1ACTGCGAAAGTATGCTGATTCTTGGTTACGGATGAC606ZAKGCGGTGGAGGAAGATTTGTGACTGAGGACCCTGAGTATTT607FOSTACTACCACTCACCCGAAGAGAATGAAGTTGGCACTGGA588MMP1AAACCCCAAAAGCGTGTGGGGTAGAAGGGATTTGTGC609DQB1CTGGTGATGATGGAAATGACTTGCTCTGGGCAGATTCA6010GUCY1A3GGAGCCGAGTCTATCTTCATGTGCTGTGCCAATGTTC6011MYL9AACGCCTTTGCCTGCTTCCATCTCGTCCACTTCCTCATC6012GJA5GGCAAGGAAATAGTAGGGTTGGCAGTCTCATTAGGG6013CSF2CCTGTGCAACCCAGATTATGGCTACCAGCAGTCAAA6014TRIMGGGTGTCCACATAATTGTTGTGCCCTAACTGGTATGTTACG6015MRPL45GAAATGTTGTCAGGGTGTTGCCTTAAAGTCACATCGCTCA6016SGK196ACCTGGAAGAAACACTAAACCGGTCGTTGGAGTCGCACA6017BCL2A1CATCATTAACTGGGGAAGAAATTATGAACTCCGCAACAAA6018NR5A2CGTGGAGGAAGGAATAAGTCAGGTCAGAGGGCATAG6019ANK3CCTATTTATGTTGATTGTTATGGCTTGGCTGGTGTCTCTAATCT6020PYHIN1AAGGAGAATGCCACAATATCTGTCTCTGGATGAAACTATGC60

Statistical analysis {#Sec17}
--------------------

Data were expressed as mean ± SEM with more than three independent experiments. The statistical significance of the comparison between groups was examined with Student's t test, and *p* \< 0.05 indicates significant differences.

Additional files
================

 {#Sec18}

**Additional file 1: Table S1.** The information of the predicted MEF2A binding sites on the proximal promoter of the DEGs. **Additional file 2: Table S2.** The genes with more than twofold change in expression in the siRNA group compared to the negative control. Up, up-regulated in MEF2A specific siRNA group; down, down-regulated in MEF2A specific siRNA group. **Additional file 3: Table S3.** Annotation for the differentially expressed genes.

MEF2A

:   myocyte enhancer factor 2A

HCAEC

:   human coronary artery endothelial cells

DEG

:   differentially expressed genes

GO

:   gene ontology

KEGG

:   Kyoto Encyclopedia of Genes and Genomes

CAD

:   coronary artery disease

SA-β-Gal

:   senescence-associated β-galactosidase

VSMC

:   vascular smooth muscle cell

PAH

:   pulmonary arterial hypertension

LDL

:   low density lipoprotein cholesterol

LDLR

:   low density lipoprotein cholesterol receptor

PPI

:   protein--protein interaction

siRNA

:   small interference RNA

AHMA

:   Agilent human mRNA array

DAVID

:   Database for Annotation, Visualization, and Integrated Discovery
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